Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A phase II study of olaparib plus cediranib in combination with standard therapy for small cell lung cancerCIRB: Adult CIRB - Early Phase EmphasisLead Group: ETCTNStatus: CompletedReview Status: Completed